Nilotinib
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Nilotinib (coding:ncit:C48375)
RxNorm: nilotinib (coding:rxcui:662281, coding:omop:1394023)
SNOMED: Nilotinib (coding:sctid:427941004, coding:omop:4176309)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (3) HC (4) | BCR::ABL1 | Chronic Myelogenous Leukemia | Nilotinib | |
| FDA (3) HC (4) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Nilotinib |